Conversely, metabolic assessments showed lower fasting insulin levels and higher fasting glucose and HbA1c levels in individuals with PWS (MetS+) than in subjects with EOB (MetS+), with no significant differences in HOMA-IR, suggesting higher insulin sensitivity in individuals with PWS (MetS+) [24]. This evidence concerns the gene INS and Prader-Willi syndrome.